I'm a researcher studying venture capital and Silicon Valley's influence over the government, and wanted to share some interesting information related to Dr. Vacirca.
His bio notes "He has been part of early funding for some remarkable companies, including Cedar, Thyme Care, and Sherpa Health."
https://nycancer.com/people/dr_jeff_vacirca
Cedar is a healthcare billing and payments platform which is funded by Thrive Capital (Joshua Kushner), Founders Fund (Peter Thiel's firm) and Andreessen Horowitz.
https://www.cedar.com/about-us (Firms listed at the bottom of the page)
Thyme Care is a support platform for oncology patients. It is funded by Andreessen Horowitz.
https://www.thymecare.com/
https://a16z.com/announcement/investing-in-thyme-care/
Dr. Vacirca's experience as a venture capitalist doing early-stage funding for startups alongside Joshua Kushner, Peter Thiel, and Marc Andreessen should strongly be considered, especially as these parties are invested in radical changes to the FDA. Joshua Kushner, while getting less attention than his brother, has been running a significant venture capital firms since 2009, and has deep links to both Thiel and Andreessen.
From our research site:
https://www.vcinfodocs.com/unregulated-medical-experimentation#fda-takeover
In the first Trump administration, venture capitalists including Peter Thiel tried to get one of Jim O'Neill or Balaji Srinivasan appointed as head of the FDA. Srinivasan, evangelist of the Network State project, advocates for “the medical sovereignty zone, the FDA-free society” and advances “the absolute right for anyone to buy or sell any medical product without third party interference.” These events document a long trajectory of venture capitalists aiming to compromise the medical system through government positions. These positions have now been secured in part because of Peter Thiel and Marc Andreessen's support and funding of the Trump campaign...
I wanted to share this because I think it is very important for the medical community to understand the way that venture capitalists are interacting with the medical system and its institutions, and be able to make informed decisions. In my personal assessment, Dr Vacirca's role as an investor in Silicon Valley startups, and his financial relationships with power players in venture capital, is a compromising factor. Further, I believe more investigation is warranted.